
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Treating hivers with anti-retroviral therapy can reduce the risk of their transmitting the virus to sexual partners by roughly 92%, according to a study published in the medical journal The Lancet. 'These results are an important finding in the search for effective HIV-prevention strategies and the strongest evidence to date that antiretroviral therapy might decrease HIV-transmission risk,' says Connie Celum, a professor of medicine and global health at the University of Washington, located in Seattle. The findings were part of the Partners in Prevention study, a six-year effort coordinated by the International Clinical Research Center at the University of Washington and funded by the Bill & Melinda Gates Foundation. More than 3,400 heterosexual couples in which only one partner had HIV were enrolled from seven African countries. At the beginning of the study, the HIV-infected members had high CD4-cell counts and were not on anti-HIV treatment. Couples were provided counseling and prevention services and were followed for up to two years, with regular CD4 measurements as well as being given treatment referrals when they became eligible for them. During the study, 349 of the HIVers started treatment at an average CD4-cell count of 198. Of the 103 HIV infections that occurred in the couples, there was only one HIV transmission after treatment initiation. In that single event the HIV-infected partner had started antiretroviral therapy about three months prior to HIV infection being first detected in her partner. Deborah Donnell, the study's lead author and a biostatistician with the Vaccine and Infectious Disease Institute at the Fred Hutchinson Cancer Research Center in Seattle, says, 'The one transmission indicated that HIV-serodiscordant couples should maintain safer-sex practices even when HIV-positive partners are on treatment.' And in fact, the proportion of couples who reported having unprotected sex decreased over time, according to the study, and the couples received frequent counseling on HIV risk reduction. Although the rate of new HIV infections has been declining worldwide, an estimated 7,400 people a day are being infected with HIV, according to the Joint United Nations Programme on HIV/AIDS. More than 60 million people have been infected with HIV since the pandemic began. AIDS-related complications are the leading cause of death in sub-Saharan Africa and are the fourth leading cause of death globally. 'Our analysis of HIV-discordant couples indicates that the risk of HIV transmission is significantly lower after HIV-infected people initiate antiretroviral therapy,' Celum says. She notes that a randomized trial is under way to determine the longer-term impact of antiretroviral meds on transmission of the virus. 'While awaiting those results,' she adds, 'our study indicates that initiation of antiretroviral therapy may have a significant public-health benefit as well as clinical advantages for the individuals being treated.' Antiretroviral therapy is known to decrease the concentration of HIV in blood plasma to low levels, the authors explain, likely making the individual less infectious to others. Viral suppression to very low levels was achieved in 70% of individuals in this study at an average of seven months after starting treatment. Transmission occurred at all CD4-count levels. However, since transmission risk was highest among people with CD4 counts less than 200 and not on treatment, findings from this observational cohort indicate that the effect of anti-HIV therapy on prevention of transmission could be greatest in people with CD4-cell counts less than 200. Additionally, the investigators found that among HIV-infected individuals with CD4 counts above 200, transmission rates were highest among those with a viral load above 50,000, suggesting that targeting this group could be an effective way to achieve further transmissions of the virus. This study suggests that starting HIVers on antiretroviral therapy ' even late in the disease ' has benefits for the individual and HIV prevention. While there is movement to initiate treatment earlier for clinical benefits and increasing recognition of the potential HIV-prevention benefits with anti-HIV treatment, especially in developing countries, many programs have insufficient resources to provide coverage to those already in need. '[Antiretroviral treatment] appears to confer a significant prevention benefit across all CD4 ranges,' Donnell says, 'and this study quantifies that more accurately.'
From our Sponsors
Most Popular
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
Plus: Featured Video
Latest Stories
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
SFAF's Dr. Tyler TerMeer says he'll continue to fight for health care for all
January 28 2025 3:00 PM
Lexi Love goes public with HIV status after Trump wipes resources from federal website
January 23 2025 11:23 AM
Plus nominated for 2025 GLAAD Media Award alongside industry giants like Vogue, People, and Variety
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM